FCGR3A and COVID-19: CD16+ patrolling monocytes were decreased in pregnant and nonpregnant women during acute COVID-19, as compared with their respective healthy and convalescent groups (Supplemental Figure 3, E and F), which is a prototypical response observed in COVID-19 (2).